Европска Унија -
Немачки -
EMA (European Medicines Agency)
nevanac
novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - ophthalmika - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
Швајцарска -
Немачки -
Swissmedic (Swiss Agency for Therapeutic Products)
nevanac augentropfensuspension
novartis pharma schweiz ag - nepafenacum - augentropfensuspension - nepafenacum 1 mg, conserv.: benzalkonii chloridum, aqua q.s. um die suspension für 1 ml. - nicht-steroidaler entzündungshemmer zur applikation am auge - synthetika
Швајцарска -
Немачки -
Swissmedic (Swiss Agency for Therapeutic Products)
nevanac 3 mg / ml augentropfensuspension
novartis pharma schweiz ag - nepafenacum - augentropfensuspension - nepafenacum 3 mg, benzalkonii chloridum 0.05 mg, carmellosum natricum, guari gummi, carbomerum 974p, acidum boricum, dinatrii edetas, propylenglycolum, natrii chloridum, natrii hydroxidum aut acidum hydrochloridum ad ph, aqua purificata q.s. ad suspensionem pro 1 ml. - nicht-steroidaler entzündungshemmer zur applikation am auge - synthetika